 | • レポートコード：MRC2Q12-05087 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：消費財 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、糖尿病用インソールのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 糖尿病用インソールのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 糖尿病用インソールの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 糖尿病用インソールのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの糖尿病用インソールの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の糖尿病用インソールの売上および2028年までの予測に焦点を当てています。 糖尿病用インソールのグローバル主要企業には、Algeos、AliMed、Physipod、PowerStep、Implus(Spenco Medics)、Comfortland Medical、Atlantic Footcare、MEGA、Orthofeet、Apexfoot.、Scholl’s Wellness、Custom Feet Insoles、Pedors、SoleTech、Svorto、CuraFootなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 糖尿病用インソール市場は、タイプとアプリケーションによって区分されます。世界の糖尿病用インソール市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 単密度糖尿病用インソール、2密度糖尿病用インソール、3密度糖尿病用インソール 【アプリケーション別セグメント】 運動靴、ブーツ、カジュアルシューズ、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 糖尿病用インソール製品概要 - タイプ別市場（単密度糖尿病用インソール、2密度糖尿病用インソール、3密度糖尿病用インソール） - アプリケーション別市場（運動靴、ブーツ、カジュアルシューズ、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の糖尿病用インソール販売量予測2017-2028 - 世界の糖尿病用インソール売上予測2017-2028 - 糖尿病用インソールの地域別販売量 - 糖尿病用インソールの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別糖尿病用インソール販売量 - 主要メーカー別糖尿病用インソール売上 - 主要メーカー別糖尿病用インソール価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（単密度糖尿病用インソール、2密度糖尿病用インソール、3密度糖尿病用インソール） - 糖尿病用インソールのタイプ別販売量 - 糖尿病用インソールのタイプ別売上 - 糖尿病用インソールのタイプ別価格 ・アプリケーション別市場規模（運動靴、ブーツ、カジュアルシューズ、その他） - 糖尿病用インソールのアプリケーション別販売量 - 糖尿病用インソールのアプリケーション別売上 - 糖尿病用インソールのアプリケーション別価格 ・北米市場 - 北米の糖尿病用インソール市場規模（タイプ別、アプリケーション別） - 主要国別の糖尿病用インソール市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの糖尿病用インソール市場規模（タイプ別、アプリケーション別） - 主要国別の糖尿病用インソール市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の糖尿病用インソール市場規模（タイプ別、アプリケーション別） - 主要国別の糖尿病用インソール市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の糖尿病用インソール市場規模（タイプ別、アプリケーション別） - 主要国別の糖尿病用インソール市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの糖尿病用インソール市場規模（タイプ別、アプリケーション別） - 主要国別の糖尿病用インソール市場規模（トルコ、サウジアラビア） ・企業情報 Algeos、AliMed、Physipod、PowerStep、Implus(Spenco Medics)、Comfortland Medical、Atlantic Footcare、MEGA、Orthofeet、Apexfoot.、Scholl’s Wellness、Custom Feet Insoles、Pedors、SoleTech、Svorto、CuraFoot ・産業チェーン及び販売チャネル分析 - 糖尿病用インソールの産業チェーン分析 - 糖尿病用インソールの原材料 - 糖尿病用インソールの生産プロセス - 糖尿病用インソールの販売及びマーケティング - 糖尿病用インソールの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 糖尿病用インソールの産業動向 - 糖尿病用インソールのマーケットドライバー - 糖尿病用インソールの課題 - 糖尿病用インソールの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Diabetic Insoles Market
Due to the COVID-19 pandemic, the global Diabetic Insoles market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Single Density Diabetic Insoles accounting for % of the Diabetic Insoles global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Athletic Shoes segment is altered to an % CAGR throughout this forecast period.
China Diabetic Insoles market size is valued at US$ million in 2021, while the US and Europe Diabetic Insoles are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Diabetic Insoles landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Diabetic Insoles include Algeos, AliMed, Physipod, PowerStep, Implus(Spenco Medics), Comfortland Medical, Atlantic Footcare, MEGA and Orthofeet, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Diabetic Insoles Scope and Segment
Diabetic Insoles market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Diabetic Insoles market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Single Density Diabetic Insoles
Dual Density Diabetic Insoles
Triple Density Diabetic Insoles
Segment by Application
Athletic Shoes
Boots
Casual Shoes
Others
By Company
Algeos
AliMed
Physipod
PowerStep
Implus(Spenco Medics)
Comfortland Medical
Atlantic Footcare
MEGA
Orthofeet
Apexfoot.
Scholl’s Wellness
Custom Feet Insoles
Pedors
SoleTech
Svorto
CuraFoot
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Diabetic Insoles Product Introduction
1.2 Market by Type
1.2.1 Global Diabetic Insoles Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Single Density Diabetic Insoles
1.2.3 Dual Density Diabetic Insoles
1.2.4 Triple Density Diabetic Insoles
1.3 Market by Application
1.3.1 Global Diabetic Insoles Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Athletic Shoes
1.3.3 Boots
1.3.4 Casual Shoes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Diabetic Insoles Sales Estimates and Forecasts 2017-2028
2.2 Global Diabetic Insoles Revenue Estimates and Forecasts 2017-2028
2.3 Global Diabetic Insoles Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Diabetic Insoles Sales by Region
2.4.1 Global Diabetic Insoles Sales by Region (2017-2022)
2.4.2 Global Sales Diabetic Insoles by Region (2023-2028)
2.5 Global Diabetic Insoles Revenue by Region
2.5.1 Global Diabetic Insoles Revenue by Region (2017-2022)
2.5.2 Global Diabetic Insoles Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Diabetic Insoles Sales by Manufacturers
3.1.1 Global Top Diabetic Insoles Manufacturers by Sales (2017-2022)
3.1.2 Global Diabetic Insoles Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Diabetic Insoles in 2021
3.2 Global Diabetic Insoles Revenue by Manufacturers
3.2.1 Global Diabetic Insoles Revenue by Manufacturers (2017-2022)
3.2.2 Global Diabetic Insoles Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Diabetic Insoles Revenue in 2021
3.3 Global Diabetic Insoles Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Diabetic Insoles Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Diabetic Insoles Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Diabetic Insoles Sales by Type
4.1.1 Global Diabetic Insoles Historical Sales by Type (2017-2022)
4.1.2 Global Diabetic Insoles Forecasted Sales by Type (2023-2028)
4.1.3 Global Diabetic Insoles Sales Market Share by Type (2017-2028)
4.2 Global Diabetic Insoles Revenue by Type
4.2.1 Global Diabetic Insoles Historical Revenue by Type (2017-2022)
4.2.2 Global Diabetic Insoles Forecasted Revenue by Type (2023-2028)
4.2.3 Global Diabetic Insoles Revenue Market Share by Type (2017-2028)
4.3 Global Diabetic Insoles Price by Type
4.3.1 Global Diabetic Insoles Price by Type (2017-2022)
4.3.2 Global Diabetic Insoles Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Diabetic Insoles Sales by Application
5.1.1 Global Diabetic Insoles Historical Sales by Application (2017-2022)
5.1.2 Global Diabetic Insoles Forecasted Sales by Application (2023-2028)
5.1.3 Global Diabetic Insoles Sales Market Share by Application (2017-2028)
5.2 Global Diabetic Insoles Revenue by Application
5.2.1 Global Diabetic Insoles Historical Revenue by Application (2017-2022)
5.2.2 Global Diabetic Insoles Forecasted Revenue by Application (2023-2028)
5.2.3 Global Diabetic Insoles Revenue Market Share by Application (2017-2028)
5.3 Global Diabetic Insoles Price by Application
5.3.1 Global Diabetic Insoles Price by Application (2017-2022)
5.3.2 Global Diabetic Insoles Price Forecast by Application (2023-2028)
6 North America
6.1 North America Diabetic Insoles Market Size by Type
6.1.1 North America Diabetic Insoles Sales by Type (2017-2028)
6.1.2 North America Diabetic Insoles Revenue by Type (2017-2028)
6.2 North America Diabetic Insoles Market Size by Application
6.2.1 North America Diabetic Insoles Sales by Application (2017-2028)
6.2.2 North America Diabetic Insoles Revenue by Application (2017-2028)
6.3 North America Diabetic Insoles Market Size by Country
6.3.1 North America Diabetic Insoles Sales by Country (2017-2028)
6.3.2 North America Diabetic Insoles Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Diabetic Insoles Market Size by Type
7.1.1 Europe Diabetic Insoles Sales by Type (2017-2028)
7.1.2 Europe Diabetic Insoles Revenue by Type (2017-2028)
7.2 Europe Diabetic Insoles Market Size by Application
7.2.1 Europe Diabetic Insoles Sales by Application (2017-2028)
7.2.2 Europe Diabetic Insoles Revenue by Application (2017-2028)
7.3 Europe Diabetic Insoles Market Size by Country
7.3.1 Europe Diabetic Insoles Sales by Country (2017-2028)
7.3.2 Europe Diabetic Insoles Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Diabetic Insoles Market Size by Type
8.1.1 Asia Pacific Diabetic Insoles Sales by Type (2017-2028)
8.1.2 Asia Pacific Diabetic Insoles Revenue by Type (2017-2028)
8.2 Asia Pacific Diabetic Insoles Market Size by Application
8.2.1 Asia Pacific Diabetic Insoles Sales by Application (2017-2028)
8.2.2 Asia Pacific Diabetic Insoles Revenue by Application (2017-2028)
8.3 Asia Pacific Diabetic Insoles Market Size by Region
8.3.1 Asia Pacific Diabetic Insoles Sales by Region (2017-2028)
8.3.2 Asia Pacific Diabetic Insoles Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Diabetic Insoles Market Size by Type
9.1.1 Latin America Diabetic Insoles Sales by Type (2017-2028)
9.1.2 Latin America Diabetic Insoles Revenue by Type (2017-2028)
9.2 Latin America Diabetic Insoles Market Size by Application
9.2.1 Latin America Diabetic Insoles Sales by Application (2017-2028)
9.2.2 Latin America Diabetic Insoles Revenue by Application (2017-2028)
9.3 Latin America Diabetic Insoles Market Size by Country
9.3.1 Latin America Diabetic Insoles Sales by Country (2017-2028)
9.3.2 Latin America Diabetic Insoles Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Diabetic Insoles Market Size by Type
10.1.1 Middle East and Africa Diabetic Insoles Sales by Type (2017-2028)
10.1.2 Middle East and Africa Diabetic Insoles Revenue by Type (2017-2028)
10.2 Middle East and Africa Diabetic Insoles Market Size by Application
10.2.1 Middle East and Africa Diabetic Insoles Sales by Application (2017-2028)
10.2.2 Middle East and Africa Diabetic Insoles Revenue by Application (2017-2028)
10.3 Middle East and Africa Diabetic Insoles Market Size by Country
10.3.1 Middle East and Africa Diabetic Insoles Sales by Country (2017-2028)
10.3.2 Middle East and Africa Diabetic Insoles Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Algeos
11.1.1 Algeos Corporation Information
11.1.2 Algeos Overview
11.1.3 Algeos Diabetic Insoles Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Algeos Diabetic Insoles Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Algeos Recent Developments
11.2 AliMed
11.2.1 AliMed Corporation Information
11.2.2 AliMed Overview
11.2.3 AliMed Diabetic Insoles Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AliMed Diabetic Insoles Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AliMed Recent Developments
11.3 Physipod
11.3.1 Physipod Corporation Information
11.3.2 Physipod Overview
11.3.3 Physipod Diabetic Insoles Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Physipod Diabetic Insoles Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Physipod Recent Developments
11.4 PowerStep
11.4.1 PowerStep Corporation Information
11.4.2 PowerStep Overview
11.4.3 PowerStep Diabetic Insoles Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 PowerStep Diabetic Insoles Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 PowerStep Recent Developments
11.5 Implus(Spenco Medics)
11.5.1 Implus(Spenco Medics) Corporation Information
11.5.2 Implus(Spenco Medics) Overview
11.5.3 Implus(Spenco Medics) Diabetic Insoles Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Implus(Spenco Medics) Diabetic Insoles Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Implus(Spenco Medics) Recent Developments
11.6 Comfortland Medical
11.6.1 Comfortland Medical Corporation Information
11.6.2 Comfortland Medical Overview
11.6.3 Comfortland Medical Diabetic Insoles Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Comfortland Medical Diabetic Insoles Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Comfortland Medical Recent Developments
11.7 Atlantic Footcare
11.7.1 Atlantic Footcare Corporation Information
11.7.2 Atlantic Footcare Overview
11.7.3 Atlantic Footcare Diabetic Insoles Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Atlantic Footcare Diabetic Insoles Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Atlantic Footcare Recent Developments
11.8 MEGA
11.8.1 MEGA Corporation Information
11.8.2 MEGA Overview
11.8.3 MEGA Diabetic Insoles Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 MEGA Diabetic Insoles Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 MEGA Recent Developments
11.9 Orthofeet
11.9.1 Orthofeet Corporation Information
11.9.2 Orthofeet Overview
11.9.3 Orthofeet Diabetic Insoles Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Orthofeet Diabetic Insoles Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Orthofeet Recent Developments
11.10 Apexfoot.
11.10.1 Apexfoot. Corporation Information
11.10.2 Apexfoot. Overview
11.10.3 Apexfoot. Diabetic Insoles Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Apexfoot. Diabetic Insoles Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Apexfoot. Recent Developments
11.11 Scholl’s Wellness
11.11.1 Scholl’s Wellness Corporation Information
11.11.2 Scholl’s Wellness Overview
11.11.3 Scholl’s Wellness Diabetic Insoles Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Scholl’s Wellness Diabetic Insoles Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Scholl’s Wellness Recent Developments
11.12 Custom Feet Insoles
11.12.1 Custom Feet Insoles Corporation Information
11.12.2 Custom Feet Insoles Overview
11.12.3 Custom Feet Insoles Diabetic Insoles Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Custom Feet Insoles Diabetic Insoles Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Custom Feet Insoles Recent Developments
11.13 Pedors
11.13.1 Pedors Corporation Information
11.13.2 Pedors Overview
11.13.3 Pedors Diabetic Insoles Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Pedors Diabetic Insoles Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Pedors Recent Developments
11.14 SoleTech
11.14.1 SoleTech Corporation Information
11.14.2 SoleTech Overview
11.14.3 SoleTech Diabetic Insoles Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 SoleTech Diabetic Insoles Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 SoleTech Recent Developments
11.15 Svorto
11.15.1 Svorto Corporation Information
11.15.2 Svorto Overview
11.15.3 Svorto Diabetic Insoles Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Svorto Diabetic Insoles Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Svorto Recent Developments
11.16 CuraFoot
11.16.1 CuraFoot Corporation Information
11.16.2 CuraFoot Overview
11.16.3 CuraFoot Diabetic Insoles Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 CuraFoot Diabetic Insoles Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 CuraFoot Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Diabetic Insoles Industry Chain Analysis
12.2 Diabetic Insoles Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Diabetic Insoles Production Mode & Process
12.4 Diabetic Insoles Sales and Marketing
12.4.1 Diabetic Insoles Sales Channels
12.4.2 Diabetic Insoles Distributors
12.5 Diabetic Insoles Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Diabetic Insoles Industry Trends
13.2 Diabetic Insoles Market Drivers
13.3 Diabetic Insoles Market Challenges
13.4 Diabetic Insoles Market Restraints
14 Key Findings in The Global Diabetic Insoles Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer